Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth By: MarketWatch October 26, 2023 at 06:32 AM EDT Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals Read More >> Related Stocks: Merck & Co
